Cargando…

Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury

BACKGROUND: Astrocytes are taking the center stage in neurotrauma and neurological diseases as they appear to play a dominant role in the inflammatory processes associated with these conditions. Previously, we reported that inhibiting NF-κB activation in astrocytes, using a transgenic mouse model (G...

Descripción completa

Detalles Bibliográficos
Autores principales: Bracchi-Ricard, Valerie, Lambertsen, Kate L, Ricard, Jerome, Nathanson, Lubov, Karmally, Shaffiat, Johnstone, Joshua, Ellman, Ditte G, Frydel, Beata, McTigue, Dana M, Bethea, John R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751509/
https://www.ncbi.nlm.nih.gov/pubmed/23880092
http://dx.doi.org/10.1186/1742-2094-10-92
_version_ 1782281612903317504
author Bracchi-Ricard, Valerie
Lambertsen, Kate L
Ricard, Jerome
Nathanson, Lubov
Karmally, Shaffiat
Johnstone, Joshua
Ellman, Ditte G
Frydel, Beata
McTigue, Dana M
Bethea, John R
author_facet Bracchi-Ricard, Valerie
Lambertsen, Kate L
Ricard, Jerome
Nathanson, Lubov
Karmally, Shaffiat
Johnstone, Joshua
Ellman, Ditte G
Frydel, Beata
McTigue, Dana M
Bethea, John R
author_sort Bracchi-Ricard, Valerie
collection PubMed
description BACKGROUND: Astrocytes are taking the center stage in neurotrauma and neurological diseases as they appear to play a dominant role in the inflammatory processes associated with these conditions. Previously, we reported that inhibiting NF-κB activation in astrocytes, using a transgenic mouse model (GFAP-IκBα-dn mice), results in improved functional recovery, increased white matter preservation and axonal sparing following spinal cord injury (SCI). In the present study, we sought to determine whether this improvement, due to inhibiting NF-κB activation in astrocytes, could be the result of enhanced oligodendrogenesis in our transgenic mice. METHODS: To assess oligodendrogenesis in GFAP-IκBα-dn compared to wild-type (WT) littermate mice following SCI, we used bromodeoxyuridine labeling along with cell-specific immuno-histochemistry, confocal microscopy and quantitative cell counts. To further gain insight into the underlying molecular mechanisms leading to increased white matter, we performed a microarray analysis in naïve and 3 days, 3 and 6 weeks following SCI in GFAP-IκBα-dn and WT littermate mice. RESULTS: Inhibition of astroglial NF-κB in GFAP-IκBα-dn mice resulted in enhanced oligodendrogenesis 6 weeks following SCI and was associated with increased levels of myelin proteolipid protein compared to spinal cord injured WT mice. The microarray data showed a large number of differentially expressed genes involved in inflammatory and immune response between WT and transgenic mice. We did not find any difference in the number of microglia/leukocytes infiltrating the spinal cord but did find differences in their level of expression of toll-like receptor 4. We also found increased expression of the chemokine receptor CXCR4 on oligodendrocyte progenitor cells and mature oligodendrocytes in the transgenic mice. Finally TNF receptor 2 levels were significantly higher in the transgenic mice compared to WT following injury. CONCLUSIONS: These studies suggest that one of the beneficial roles of blocking NF-κB in astrocytes is to promote oligodendrogenesis through alteration of the inflammatory environment.
format Online
Article
Text
id pubmed-3751509
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37515092013-08-24 Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury Bracchi-Ricard, Valerie Lambertsen, Kate L Ricard, Jerome Nathanson, Lubov Karmally, Shaffiat Johnstone, Joshua Ellman, Ditte G Frydel, Beata McTigue, Dana M Bethea, John R J Neuroinflammation Research BACKGROUND: Astrocytes are taking the center stage in neurotrauma and neurological diseases as they appear to play a dominant role in the inflammatory processes associated with these conditions. Previously, we reported that inhibiting NF-κB activation in astrocytes, using a transgenic mouse model (GFAP-IκBα-dn mice), results in improved functional recovery, increased white matter preservation and axonal sparing following spinal cord injury (SCI). In the present study, we sought to determine whether this improvement, due to inhibiting NF-κB activation in astrocytes, could be the result of enhanced oligodendrogenesis in our transgenic mice. METHODS: To assess oligodendrogenesis in GFAP-IκBα-dn compared to wild-type (WT) littermate mice following SCI, we used bromodeoxyuridine labeling along with cell-specific immuno-histochemistry, confocal microscopy and quantitative cell counts. To further gain insight into the underlying molecular mechanisms leading to increased white matter, we performed a microarray analysis in naïve and 3 days, 3 and 6 weeks following SCI in GFAP-IκBα-dn and WT littermate mice. RESULTS: Inhibition of astroglial NF-κB in GFAP-IκBα-dn mice resulted in enhanced oligodendrogenesis 6 weeks following SCI and was associated with increased levels of myelin proteolipid protein compared to spinal cord injured WT mice. The microarray data showed a large number of differentially expressed genes involved in inflammatory and immune response between WT and transgenic mice. We did not find any difference in the number of microglia/leukocytes infiltrating the spinal cord but did find differences in their level of expression of toll-like receptor 4. We also found increased expression of the chemokine receptor CXCR4 on oligodendrocyte progenitor cells and mature oligodendrocytes in the transgenic mice. Finally TNF receptor 2 levels were significantly higher in the transgenic mice compared to WT following injury. CONCLUSIONS: These studies suggest that one of the beneficial roles of blocking NF-κB in astrocytes is to promote oligodendrogenesis through alteration of the inflammatory environment. BioMed Central 2013-07-23 /pmc/articles/PMC3751509/ /pubmed/23880092 http://dx.doi.org/10.1186/1742-2094-10-92 Text en Copyright © 2013 Bracchi-Ricard et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Bracchi-Ricard, Valerie
Lambertsen, Kate L
Ricard, Jerome
Nathanson, Lubov
Karmally, Shaffiat
Johnstone, Joshua
Ellman, Ditte G
Frydel, Beata
McTigue, Dana M
Bethea, John R
Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title_full Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title_fullStr Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title_full_unstemmed Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title_short Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury
title_sort inhibition of astroglial nf-kappab enhances oligodendrogenesis following spinal cord injury
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751509/
https://www.ncbi.nlm.nih.gov/pubmed/23880092
http://dx.doi.org/10.1186/1742-2094-10-92
work_keys_str_mv AT bracchiricardvalerie inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT lambertsenkatel inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT ricardjerome inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT nathansonlubov inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT karmallyshaffiat inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT johnstonejoshua inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT ellmanditteg inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT frydelbeata inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT mctiguedanam inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury
AT betheajohnr inhibitionofastroglialnfkappabenhancesoligodendrogenesisfollowingspinalcordinjury